Related Experiment Video
Updated: Apr 11, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues
Antonella Accardo1, Giancarlo Morelli1
1Department of Pharmacy, CIRPeB, University of Naples "Federico II" and Invectors srl, 80134, Napoli, Italy.
Abstract:
We describe the use of bioactive peptides to drive liposomal drugs on target receptors overexpressed in cancer cells. A detailed description for several targeting liposomes derivatized with different peptides and thus able to target relevant receptors for cancer therapy is reported. Even if the development of peptide-targeted liposomes represents a great advance in the use of liposomal drugs for cancer therapy, many critical issues are still unsolved in the development of these innovative drug delivery systems. Advantages and drawbacks of the peptide-mediated active targeting are discussed.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Drug Permeability Enhancement
Targeted Cancer Therapies
There are several types of targeted therapies against...

